A Study to Assess Therapeutic Equivalence Between Test EMLA Patch With Marketed EMLA Patch in Healthy Subjects.
Clinical trial NCT03313336 · COMPLETED
Trial details
- NCT number
- NCT03313336
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-30
- Primary completion
- 2017-11-09
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.